Distribution agreement for BioPen with Swift Analytical
Fluicell announces an agreement with Swift Analytical Ltd regarding distribution of BioPen System in the United Kingdom. Through the agreement with Swift Analytical, a company with a long-standing expertise in research tools for life science and microfluidic technology, Fluicell strengthen its position on the United Kingdom market.
Victoire Viannay, CEO Fluicell:
With this agreement, we continue to develop our network of distributors and thus our presence in important markets. Swift Analytical is a recognized player with 20 years of experience in providing researchers in the UK with life science instruments. The fact that the company has a strong history in microfluidics will be a valuable asset for Fluicell
Mebs Surve, Managing Director Swift Analytical:
We are delighted to be selected as the UK distributor for Fluicell’s ground breaking products utilising the BioPen perfusion technology. To be able to directly influence and observe individual or small groups of cells will significantly aid researchers to develop a better understanding of single cell biology in a broad range of disciplines in the areas of life science and medical research.
Read the full press release in Swedish here.
Read more about BioPen here.